These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 28795996

  • 1. Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.
    Yu SJ, Kwon JH, Kim W, Yoon JH, Lee JM, Lee JY, Cho EJ, Lee JH, Kim HY, Jung YJ, Kim YJ.
    J Clin Gastroenterol; 2018 Mar; 52(3):e18-e26. PubMed ID: 28795996
    [Abstract] [Full Text] [Related]

  • 2. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
    Seo JY, Kim W, Kwon JH, Jin EH, Yu SJ, Kim HY, Jung YJ, Kim D, Kim YJ, Yoon JH, Lee HS.
    Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
    [Abstract] [Full Text] [Related]

  • 4. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S, Rhim H, Kim YS, Kang TW, Song KD.
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [Abstract] [Full Text] [Related]

  • 5. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation.
    Kim JS, Kim W, So YH, Yu SJ, Kim BG.
    J Clin Gastroenterol; 2014 Jan; 48(1):66-72. PubMed ID: 23751848
    [Abstract] [Full Text] [Related]

  • 6. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
    Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Wu JC, Huo TI, Huang YH, Wu WC, Lin HC, Lee SD.
    Clin Radiol; 2012 May; 67(5):429-36. PubMed ID: 22153231
    [Abstract] [Full Text] [Related]

  • 7. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC.
    Int J Cancer; 2004 Oct 20; 112(1):44-50. PubMed ID: 15305374
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
    Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, Joh JW, Park CK.
    Ann Surg Oncol; 2007 Aug 20; 14(8):2319-29. PubMed ID: 17522947
    [Abstract] [Full Text] [Related]

  • 9. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
    Mohkam K, Dumont PN, Manichon AF, Jouvet JC, Boussel L, Merle P, Ducerf C, Lesurtel M, Rode A, Mabrut JY.
    J Hepatol; 2018 Jun 20; 68(6):1172-1180. PubMed ID: 29410287
    [Abstract] [Full Text] [Related]

  • 10. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
    Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Lin HC, Lee SD, Wu JC.
    J Clin Gastroenterol; 2012 Jan 20; 46(1):62-70. PubMed ID: 21934530
    [Abstract] [Full Text] [Related]

  • 11. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.
    Umeda Y, Matsuda H, Sadamori H, Matsukawa H, Yagi T, Fujiwara T.
    World J Surg; 2011 Jan 20; 35(1):170-7. PubMed ID: 20922387
    [Abstract] [Full Text] [Related]

  • 12. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
    Tanaka T, Takata K, Kunimoto H, Fukuda H, Yamauchi R, Tsuchiya N, Inomata S, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.
    Oncology; 2020 Jan 20; 98(12):859-868. PubMed ID: 32799203
    [Abstract] [Full Text] [Related]

  • 13. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
    Takada H, Tsuchiya K, Yasui Y, Nakakuki N, Tamaki N, Suzuki S, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Asahina Y, Enomoto N, Izumi N.
    Cancer Med; 2016 Nov 20; 5(11):3111-3120. PubMed ID: 27748052
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation.
    Yang W, Wu H, Zhang ZY, Lee JC, Wang S, Wang YJ, Wu W, Chen MH, Yan K.
    Int J Hyperthermia; 2018 Feb 20; 34(1):68-76. PubMed ID: 28540818
    [Abstract] [Full Text] [Related]

  • 15. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ, Rochon PJ, Chang S, Ray CE, Winston H, Ruef R, Kreidler SM, Glueck DH, Shulman BC, Brown AC, Durham J.
    J Vasc Interv Radiol; 2013 Nov 20; 24(11):1613-22. PubMed ID: 24060436
    [Abstract] [Full Text] [Related]

  • 16. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
    Lu B, Zhu L, Wang X, Zhong L, Cheng Y, Fan J, Yu L.
    J BUON; 2019 Nov 20; 24(5):1979-1984. PubMed ID: 31786864
    [Abstract] [Full Text] [Related]

  • 17. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
    Zhang W, Luo E, Gan J, Song X, Bao Z, Zhang H, Chen M.
    World J Surg Oncol; 2017 Jul 05; 15(1):122. PubMed ID: 28679433
    [Abstract] [Full Text] [Related]

  • 18. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
    Kim N, Cheng J, Jung I, Liang J, Shih YL, Huang WY, Kimura T, Lee VHF, Zeng ZC, Zhenggan R, Kay CS, Heo SJ, Won JY, Seong J.
    J Hepatol; 2020 Jul 05; 73(1):121-129. PubMed ID: 32165253
    [Abstract] [Full Text] [Related]

  • 19. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
    Blank S, Wang Q, Fiel MI, Luan W, Kim KW, Kadri H, Mandeli J, Hiotis SP.
    Ann Surg Oncol; 2014 Mar 05; 21(3):986-94. PubMed ID: 24232510
    [Abstract] [Full Text] [Related]

  • 20. Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Lee JS, Chon YE, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kang W, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Kim HY, Kim TH, Yoo K, Ha Y, Kim MN, Lee JH, Hwang SG, Kim SS, Cho HJ, Cheong JY, Cho SW, Park SH, Heo NY, Hong YM, Yoon KT, Cho M, Park JG, Kang MK, Park SY, Kweon YO, Tak WY, Jang SY, Sinn DH, Kim SU, Korean TACE Study Group.
    Yonsei Med J; 2021 Jan 05; 62(1):12-20. PubMed ID: 33381930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.